Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
47.91
+0.48 (1.01%)
At close: Dec 5, 2025, 4:00 PM EST
48.43
+0.52 (1.09%)
After-hours: Dec 5, 2025, 6:53 PM EST
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 357 employees as of December 31, 2024. The number of employees increased by 160 or 81.22% compared to the previous year.
Employees
357
Change (1Y)
160
Growth (1Y)
81.22%
Revenue / Employee
$2,120,636
Profits / Employee
$163,706
Market Cap
1.51B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COLL News
- 24 days ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - Collegium Pharmaceutical: Another Solid Quarter - Seeking Alpha
- 4 weeks ago - Collegium Pharmaceutical, Inc. (COLL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance - GlobeNewsWire
- 5 weeks ago - Knight Therapeutics Announces Launch of JORNAY PM™ in Canada - GlobeNewsWire
- 6 weeks ago - Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewsWire
- 6 weeks ago - Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences - GlobeNewsWire
- 7 weeks ago - Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing - GlobeNewsWire